Sialic acids have
diverse biological roles, ranging from promoting
up to preventing protein and cellular recognition in health and disease.
The various functions of these monosaccharides are owed, in part,
to linkage variants, and as a result, linkage-specific analysis of
sialic acids is an important aspect of glycomic studies. This has
been addressed by derivatization strategies using matrix-assisted
laser desorption/ionization mass spectrometry (MS) or sialidase digestion
arrays followed by liquid chromatography (LC)-MS. Despite this, these
approaches are unable to simultaneously provide unambiguous assignment
of sialic acid linkages and assess further isomeric glycan features
within a single measurement. Thus, for the first time, we present
the combination of procainamide fluorescent labeling with sialic acid
linkage-specific derivatization via ethyl esterification and amidation
for the analysis of released plasma
N
-glycans using
reversed-phase (RP)LC-fluorescence detection (FD)-MS. As a result,
α2,3- and α2,6-sialylated
N
-glycans,
with the same mass prior to derivatization, are differentiated based
on retention time, precursor mass, and fragmentation spectra, and
additional sialylated isomers were also separated. Furthermore, improved
glycan coverage and protocol precision were found via the novel application
using a combined FD-MS quantification approach. Overall, this platform
achieved unambiguous assignment of
N
-glycan sialic
acid linkages within a single RPLC-FD-MS measurement, and by improving
their retention on RPLC, this technique can be used for future investigations
of released
N
-glycans as an additional or orthogonal
method to current analytical approaches.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.